Water Works
This episode of the Value Chronicles was all about partnerships and making an excellent agent to cement relationships and deliver world-class service. Two long-time partners of Cla-Val joined host Tyler Kern to tackle this vital topic. Raeann Velasquez, Chief Executive Officer and Outside Sales Manager for Cimco-GC Systems, and Robb White, Regional Sales Manager at…
Latest
Building Management
How This California Town Utilizes Link2Valves for its Water System
“The other thing I think is really nice is the monthly report you can get sent to you in email format,” Neumann said. “When you have a bunch of different job duties, it is important to get that reminder.” The app Link2Valves helps to make faster, more intelligent decisions on water system infrastructure. It has…
Building Management
The Valve Chronicles: Replacing Aging Infrastructure of Control Valve Vaults in the U.S.
Robb White, Regional Sales Manager at ESI Fab Systems, broke down the aging infrastructure of control valve vaults in the United States and detailed the process of fixing the issue. White said the problem is widespread across the United States from coast to coast. “These control valve vaults are underground; they’re in concrete structures,” White…
Building Management
Valve Chronicles: Preventative Maintenance
For any parts in a mechanical process, preventative maintenance is critical for a longer, useful life. That’s true for valves in water systems. On Valve Chronicles, host Tyler Kern spoke with Jake Corzine, Western Regional Manager, Cla-Val, and Randy Harris, EMT Superintendent, California Water, about the subject. Harris’ role with Cal Water is to manage a…
Engineering & Construction
Valve Chronicles: Cla-Val University is Back with Online Training Sessions
George Aguilar, Training Manager at Cla-Val, provided some exciting news for industries looking for Cla-Val valve training. CVU (Cla-Val University) is back. The pandemic may have halted in-person training sessions for the time being, but CVU is now running online training sessions through Zoom. “We’re providing online courses for operators and end users on our…
Engineering & Construction
Setting Yourself Up for Control Valve Success
Cla-Val features leading experts in automatic control valves and flow control solutions – so they know the steps users should deploy to set themselves up for success. The biggest pitfalls can generally be avoided by something as simple as clear communication, said Jake Corzine, Western Regional Sales Manager for Cla-Val. “When I’m talking to…
Engineering & Construction
Meeting Valve Sizing and Noise Requirements with Innovative Software Solutions
On this episode of Valve Chronicles, a Cla-Val podcast, Daniel Litwin hosts Roger Lah, Technical Product Specialist for Cla-Val. The duo explored how technical software can help industrial water professionals analyze and meet their valve sizing and noise requirements. Cla-Val’s products are made to refine valve noise and have adaptable sizing software to meet difficult…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…